OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,247,971 | -39.1% | 397,443 | 0.0% | 0.02% | -33.3% |
Q2 2023 | $2,050,806 | +45.3% | 397,443 | +48.4% | 0.03% | +28.6% |
Q1 2023 | $1,411,775 | +53.0% | 267,889 | -18.4% | 0.02% | +50.0% |
Q4 2022 | $922,562 | -37.0% | 328,314 | -6.9% | 0.01% | -30.0% |
Q3 2022 | $1,464,000 | -34.5% | 352,811 | -36.5% | 0.02% | -33.3% |
Q2 2022 | $2,235,000 | – | 555,884 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
Covestor Ltd | 37,404 | $117 | 0.09% |
GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |